{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:02:36Z","timestamp":1790632956756,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Loss-of-function mutations in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) channel in human airway epithelial cells are responsible for Cystic Fibrosis. A deleterious impact of physiological temperature on CFTR plasma membrane expression, residence and channel activity is characteristic of the most common and severe CF mutation, F508del. Using primary human F508del-airway epithelial cells and CF bronchial epithelial CFBE41o- cell lines expressing F508del- or WT-CFTR, we examined the effects of temperature (29\u2009\u00b0C-39\u2009\u00b0C) on the amplitude and stability of short-circuit CFTR-dependent currents over time and the efficiency of pharmacological strategies to stably restore F508del-CFTR function. We show that F508del-CFTR functional instability at 37\u2009\u00b0C is not prevented by low temperature or VX-809 correction, genistein and VX-770 potentiators, nor by the combination VX-809\/VX-770. Moreover, F508del-CFTR-dependent currents 30\u2009minutes after CFTR activation at 37\u2009\u00b0C did not significantly differ whether a potentiator was used or not. We demonstrate that F508del-CFTR function loss is aggravated at temperatures above 37\u2009\u00b0C while limited by a small decrease of temperature and show that the more F508del-CFTR is stimulated, the faster the current loss happens. Our study highlights the existence of a temperature-dependent process inhibiting the function of F508del-CFTR, possibly explaining the low efficacy of pharmacological drugs in clinic.<\/jats:p>","DOI":"10.1038\/s41598-019-50066-7","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T10:03:28Z","timestamp":1569319408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Short-term consequences of F508del-CFTR thermal instability on CFTR-dependent transepithelial currents in human airway epithelial cells"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4517-0877","authenticated-orcid":false,"given":"Lionel","family":"Froux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Coraux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Sage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Becq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"50066_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev.ph.55.030193.003141","volume":"55","author":"JR Riordan","year":"1993","unstructured":"Riordan, J. R. The cystic fibrosis transmembrane conductance regulator. Annu. Rev. Physiol. 55, 609\u2013630 (1993).","journal-title":"Annu. Rev. Physiol."},{"key":"50066_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","volume":"245","author":"JR Riordan","year":"1989","unstructured":"Riordan, J. R. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066\u20131073 (1989).","journal-title":"Science"},{"key":"50066_CR3","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1056\/NEJMra043184","volume":"352","author":"SM Rowe","year":"2005","unstructured":"Rowe, S. M., Miller, S. & Sorscher, E. J. Cystic Fibrosis. N. Engl. J. Med. 352, 1992\u20132001 (2005).","journal-title":"N. Engl. J. Med."},{"key":"50066_CR4","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ng.2745","volume":"45","author":"PR Sosnay","year":"2013","unstructured":"Sosnay, P. R. et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat. Genet. 45, 1160\u20131167 (2013).","journal-title":"Nat. Genet."},{"key":"50066_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0092-8674(90)90148-8","volume":"63","author":"SH Cheng","year":"1990","unstructured":"Cheng, S. H. et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827\u2013834 (1990).","journal-title":"Cell"},{"key":"50066_CR6","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1083\/jcb.118.3.551","volume":"118","author":"GM Denning","year":"1992","unstructured":"Denning, G. M., Ostedgaard, L. S. & Welsh, M. J. Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. J. Cell Biol. 118, 551\u2013559 (1992).","journal-title":"J. Cell Biol."},{"key":"50066_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng0892-321","volume":"1","author":"N Kartner","year":"1992","unstructured":"Kartner, N., Augustinas, O., Jensen, T. J., Naismith, A. L. & Riordan, J. R. Mislocalization of \u0394F508 CFTR in cystic fibrosis sweat gland. Nat. Genet. 1, 321\u2013327 (1992).","journal-title":"Nat. Genet."},{"key":"50066_CR8","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1016\/S0021-9258(18)42610-5","volume":"267","author":"PJ Thomas","year":"1992","unstructured":"Thomas, P. J., Shenbagamurthi, P., Sondek, J., Hullihen, J. M. & Pedersen, P. L. The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide. J. Biol. Chem. 267, 5727\u20135730 (1992).","journal-title":"J. Biol. Chem."},{"key":"50066_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/354526a0","volume":"354","author":"W Dalemans","year":"1991","unstructured":"Dalemans, W. et al. Altered chloride ion channel kinetics associated with the \u0394F508 cystic fibrosis mutation. Nature 354, 526\u2013528 (1991).","journal-title":"Nature"},{"key":"50066_CR10","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1016\/S0021-9258(20)80582-1","volume":"268","author":"GL Lukacs","year":"1993","unstructured":"Lukacs, G. L. et al. The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J. Biol. Chem. 268, 21592\u201321598 (1993).","journal-title":"J. Biol. Chem."},{"key":"50066_CR11","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1091\/mbc.e04-03-0176","volume":"15","author":"M Gentzsch","year":"2004","unstructured":"Gentzsch, M. et al. Endocytic trafficking routes of wild type and \u0394F508 cystic fibrosis transmembrane conductance regulator. Mol. Biol. Cell 15, 2684\u20132696 (2004).","journal-title":"Mol. Biol. Cell"},{"key":"50066_CR12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1083\/jcb.200312018","volume":"164","author":"M Sharma","year":"2004","unstructured":"Sharma, M. et al. Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. J. Cell Biol. 164, 923\u2013933 (2004).","journal-title":"J. Cell Biol."},{"key":"50066_CR13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1191542","volume":"329","author":"T Okiyoneda","year":"2010","unstructured":"Okiyoneda, T. et al. Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science 329, 805\u2013810 (2010).","journal-title":"Science"},{"key":"50066_CR14","doi-asserted-by":"publisher","first-page":"18825","DOI":"10.1073\/pnas.0904709106","volume":"106","author":"F Van Goor","year":"2009","unstructured":"Van Goor, F. et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc. Natl. Acad. Sci. 106, 18825\u201318830 (2009).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"50066_CR15","doi-asserted-by":"publisher","first-page":"18843","DOI":"10.1073\/pnas.1105787108","volume":"108","author":"F Van Goor","year":"2011","unstructured":"Van Goor, F. et al. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc. Natl. Acad. Sci. 108, 18843\u201318848 (2011).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"50066_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1056\/NEJMoa1409547","volume":"373","author":"CE Wainwright","year":"2015","unstructured":"Wainwright, C. E. et al. Lumacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del. CFTR. N. Engl. J. Med. 373, 220\u2013231 (2015).","journal-title":"CFTR. N. Engl. J. Med."},{"key":"50066_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/358761a0","volume":"358","author":"GM Denning","year":"1992","unstructured":"Denning, G. M. et al. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761\u2013764 (1992).","journal-title":"Nature"},{"key":"50066_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cell.2011.11.024","volume":"148","author":"WM Rabeh","year":"2012","unstructured":"Rabeh, W. M. et al. Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore \u0394F508 CFTR Folding and Function. Cell 148, 150\u2013163 (2012).","journal-title":"Cell"},{"key":"50066_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bbamem.2006.03.006","volume":"1758","author":"T Heged\u0171s","year":"2006","unstructured":"Heged\u0171s, T. et al. F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive. Biochim. Biophys. Acta BBA - Biomembr. 1758, 565\u2013572 (2006).","journal-title":"Biochim. Biophys. Acta BBA - Biomembr."},{"key":"50066_CR20","doi-asserted-by":"publisher","first-page":"41937","DOI":"10.1074\/jbc.M111.296061","volume":"286","author":"W Wang","year":"2011","unstructured":"Wang, W., Okeyo, G. O., Tao, B., Hong, J. S. & Kirk, K. L. Thermally Unstable Gating of the Most Common Cystic Fibrosis Mutant Channel (\u0394F508): \u201cRescue\u201d by Suppressor Mutations in Nucleotide Binding Domain 1 and by Constitutive Mutations in the Cytosolic Loops. J. Biol. Chem. 286, 41937\u201341948 (2011).","journal-title":"J. Biol. Chem."},{"key":"50066_CR21","doi-asserted-by":"publisher","first-page":"L846","DOI":"10.1152\/ajplung.00235.2018","volume":"315","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Cai, Z., Gosling, M. & Sheppard, D. N. Potentiation of the cystic fibrosis transmembrane conductance regulator Cl\u2212 channel by ivacaftor is temperature independent. Am. J. Physiol.-Lung Cell. Mol. Physiol. 315, L846\u2013L857 (2018).","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"50066_CR22","doi-asserted-by":"publisher","first-page":"8942","DOI":"10.1074\/jbc.M009172200","volume":"276","author":"M Sharma","year":"2001","unstructured":"Sharma, M., Benharouga, M., Hu, W. & Lukacs, G. L. Conformational and Temperature-sensitive Stability Defects of the \u0394F508 Cystic Fibrosis Transmembrane Conductance Regulator in Post-endoplasmic Reticulum Compartments. J. Biol. Chem. 276, 8942\u20138950 (2001).","journal-title":"J. Biol. Chem."},{"key":"50066_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1165\/rcmb.2008-0434OC","volume":"42","author":"A Jurkuvenaite","year":"2010","unstructured":"Jurkuvenaite, A. et al. Functional Stability of Rescued \u0394F508 Cystic Fibrosis Transmembrane Conductance Regulator in Airway Epithelial Cells. Am. J. Respir. Cell Mol. Biol. 42, 363\u2013372 (2010).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"50066_CR24","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1021\/bi300018e","volume":"51","author":"X Liu","year":"2012","unstructured":"Liu, X., O\u2019Donnell, N., Landstrom, A., Skach, W. R. & Dawson, D. C. Thermal Instability of \u0394F508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channel Function: Protection by Single Suppressor Mutations and Inhibiting Channel Activity. Biochemistry 51, 5113\u20135124 (2012).","journal-title":"Biochemistry"},{"key":"50066_CR25","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1124\/jpet.114.214890","volume":"350","author":"C Boinot","year":"2014","unstructured":"Boinot, C., Jollivet Souchet, M., Ferru-Clement, R. & Becq, F. Searching for Combinations of Small-Molecule Correctors to Restore F508del-Cystic Fibrosis Transmembrane Conductance Regulator Function and Processing. J. Pharmacol. Exp. Ther. 350, 624\u2013634 (2014).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"50066_CR26","doi-asserted-by":"crossref","unstructured":"Billet, A., Froux, L., Hanrahan, J. W. & Becq, F. Development of Automated Patch Clamp Technique to Investigate CFTR Chloride Channel Function. Front. Pharmacol. 8 (2017).","DOI":"10.3389\/fphar.2017.00195"},{"key":"50066_CR27","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1074\/jbc.M116.751537","volume":"292","author":"X Meng","year":"2017","unstructured":"Meng, X. et al. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation. J. Biol. Chem. 292, 3706\u20133719 (2017).","journal-title":"J. Biol. Chem."},{"key":"50066_CR28","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1172\/JCI0216112","volume":"110","author":"T Ma","year":"2002","unstructured":"Ma, T. et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin\u2013induced intestinal fluid secretion. J. Clin. Invest. 110, 1651\u20131658 (2002).","journal-title":"J. Clin. Invest."},{"key":"50066_CR29","doi-asserted-by":"publisher","first-page":"246ra97","DOI":"10.1126\/scitranslmed.3008889","volume":"6","author":"G Veit","year":"2014","unstructured":"Veit, G. et al. Some gating potentiators, including VX-770, diminish F508-CFTR functional expression. Sci. Transl. Med. 6, 246ra97\u2013246ra97 (2014).","journal-title":"Sci. Transl. Med."},{"key":"50066_CR30","doi-asserted-by":"publisher","first-page":"246ra96","DOI":"10.1126\/scitranslmed.3008680","volume":"6","author":"DM Cholon","year":"2014","unstructured":"Cholon, D. M. et al. Potentiator ivacaftor abrogates pharmacological correction of F508 CFTR in cystic fibrosis. Sci. Transl. Med. 6, 246ra96\u2013246ra96 (2014).","journal-title":"Sci. Transl. Med."},{"key":"50066_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/23808993.2016.1175299","volume":"1","author":"DM Cholon","year":"2016","unstructured":"Cholon, D. M., Esther, C. R. & Gentzsch, M. Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation. Expert Rev. Precis. Med. Drug Dev. 1, 235\u2013243 (2016).","journal-title":"Expert Rev. Precis. Med. Drug Dev."},{"key":"50066_CR32","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1807119","volume":"379","author":"JC Davies","year":"2018","unstructured":"Davies, J. C. et al. VX-659\u2013Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N. Engl. J. Med. 379, 1599\u20131611 (2018).","journal-title":"N. Engl. J. Med."},{"key":"50066_CR33","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","volume":"379","author":"D Keating","year":"2018","unstructured":"Keating, D. et al. VX-445\u2013Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N. Engl. J. Med. 379, 1612\u20131620 (2018).","journal-title":"N. Engl. J. Med."},{"key":"50066_CR34","doi-asserted-by":"publisher","first-page":"e27784","DOI":"10.1371\/journal.pone.0027784","volume":"6","author":"JM Collaco","year":"2011","unstructured":"Collaco, J. M. et al. Effect of Temperature on Cystic Fibrosis Lung Disease and Infections: A Replicated Cohort Study. PLoS ONE 6, e27784 (2011).","journal-title":"PLoS ONE"},{"key":"50066_CR35","doi-asserted-by":"publisher","first-page":"e0191409","DOI":"10.1371\/journal.pone.0191409","volume":"13","author":"JM Collaco","year":"2018","unstructured":"Collaco, J. M., Appel, L. J., McGready, J. & Cutting, G. R. The relationship of lung function with ambient temperature. PLOS ONE 13, e0191409 (2018).","journal-title":"PLOS ONE"},{"issue":"46","key":"50066_CR36","doi-asserted-by":"publisher","first-page":"17685","DOI":"10.1074\/jbc.RA117.000819","volume":"293","author":"Chi Wang","year":"2018","unstructured":"Wang, C. et al. Ligand binding to a remote site thermodynamically corrects the F508del mutation in the human cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. jbc.RA117 000819, https:\/\/doi.org\/10.1074\/jbc.RA117.000819 (2018).","journal-title":"Journal of Biological Chemistry"},{"key":"50066_CR37","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1073\/pnas.88.14.6003","volume":"88","author":"MP Anderson","year":"1991","unstructured":"Anderson, M. P. & Welsh, M. J. Calcium and cAMP activate different chloride channels in the apical membrane of normal and cystic fibrosis epithelia. Proc. Natl. Acad. Sci. 88, 6003\u20136007 (1991).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"50066_CR38","doi-asserted-by":"publisher","first-page":"C1464","DOI":"10.1152\/ajpcell.1994.266.5.C1464","volume":"266","author":"EM Schwiebert","year":"1994","unstructured":"Schwiebert, E. M., Flotte, T., Cutting, G. R. & Guggino, W. B. Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents. Am. J. Physiol.-Cell Physiol. 266, C1464\u2013C1477 (1994).","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"50066_CR39","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1113\/jphysiol.1996.sp021719","volume":"496","author":"P Linsdell","year":"1996","unstructured":"Linsdell, P. & Hanrahan, J. W. Disulphonic stilbene block of cystic fibrosis transmembrane conductance regulator Cl-channels expressed in a mammalian cell line and its regulation by a critical pore residue. J. Physiol. 496, 687\u2013693 (1996).","journal-title":"J. Physiol."},{"key":"50066_CR40","doi-asserted-by":"publisher","first-page":"C1555","DOI":"10.1152\/ajpcell.1998.275.6.C1555","volume":"275","author":"A Tousson","year":"1998","unstructured":"Tousson, A., Van Tine, B. A., Naren, A. P., Shaw, G. M. & Schwiebert, L. M. Characterization of CFTR expression and chloride channel activity in human endothelia. Am. J. Physiol.-Cell Physiol. 275, C1555\u2013C1564 (1998).","journal-title":"Am. J. Physiol.-Cell Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50066-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50066-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50066-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:49:08Z","timestamp":1671284948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50066-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,24]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50066"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50066-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,24]]},"assertion":[{"value":"30 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13729"}}